GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnamed Holdings Corp (OTCPK:DGNMF) » Definitions » EV-to-FCF

DGNMF (Diagnamed Holdings) EV-to-FCF : -5.42 (As of Mar. 24, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Diagnamed Holdings EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Diagnamed Holdings's Enterprise Value is $1.38 Mil. Diagnamed Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.25 Mil. Therefore, Diagnamed Holdings's EV-to-FCF for today is -5.42.

The historical rank and industry rank for Diagnamed Holdings's EV-to-FCF or its related term are showing as below:

DGNMF' s EV-to-FCF Range Over the Past 10 Years
Min: -7.75   Med: 0   Max: 0
Current: -6.82

DGNMF's EV-to-FCF is ranked worse than
100% of 398 companies
in the Healthcare Providers & Services industry
Industry Median: 17.38 vs DGNMF: -6.82

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-24), Diagnamed Holdings's stock price is $0.032. Diagnamed Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.008. Therefore, Diagnamed Holdings's PE Ratio (TTM) for today is At Loss.


Diagnamed Holdings EV-to-FCF Historical Data

The historical data trend for Diagnamed Holdings's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnamed Holdings EV-to-FCF Chart

Diagnamed Holdings Annual Data
Trend Sep21 Sep22 Sep23 Sep24
EV-to-FCF
- - -2.43 -1.43

Diagnamed Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.47 -4.31 -2.81 -1.43 -7.82

Competitive Comparison of Diagnamed Holdings's EV-to-FCF

For the Health Information Services subindustry, Diagnamed Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnamed Holdings's EV-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Diagnamed Holdings's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Diagnamed Holdings's EV-to-FCF falls into.



Diagnamed Holdings EV-to-FCF Calculation

Diagnamed Holdings's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1.376/-0.254
=-5.42

Diagnamed Holdings's current Enterprise Value is $1.38 Mil.
Diagnamed Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diagnamed Holdings  (OTCPK:DGNMF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Diagnamed Holdings's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.032/-0.008
=At Loss

Diagnamed Holdings's share price for today is $0.032.
Diagnamed Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.008.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Diagnamed Holdings EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Diagnamed Holdings's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Diagnamed Holdings Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its products include, CERVAI which is a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It is also investigating other technological applications such as BrainAge and BrainTremor.